» Articles » PMID: 36789269

How to Improve the Clinical Outcome of Round Spermatid Injection (ROSI) into the Oocyte: Correction of Epigenetic Abnormalities

Overview
Journal Reprod Med Biol
Specialty Biology
Date 2023 Feb 15
PMID 36789269
Authors
Affiliations
Soon will be listed here.
Abstract

Background: First successful human round spermatid injection (ROSI) was conducted by Tesarik et al. in 1996 for the sole treatment of nonobstructive azoospermic men whose most advanced spermatogenic cells were elongating round spermatids. Nine offsprings from ROSI were reported between 1996 and 2000. No successful deliveries were reported for 15 years after that. Tanaka et al. reported 90 babies born after ROSI and their follow-up studies in 2015 and 2018 showed no significant differences in comparison with those born after natural conception in terms of physical and cognitive abilities. However, clinical outcomes remain low.

Method: Clinical and laboratory data of successful cases in the precursor ROSI groups and those of Tanaka et al. were reviewed.

Results: Differences were found between the two groups in terms of identification of characteristics of round spermatid and oocyte activation. Additionally, epigenetic abnormalities were identified as underlying causes for poor ROSI results, besides correct identification of round spermatid and adequate oocyte activation. Correction of epigenetic errors could lead to optimal embryonic development.

Conclusion: Correction of epigenetic abnormalities has a probability to improve the clinical outcome of ROSI.

Citing Articles

Spermatocytes have the capacity to segregate chromosomes despite centriole duplication failure.

Skinner M, Simington C, Lopez-Jimenez P, Baran K, Xu J, Dayani Y EMBO Rep. 2024; 25(8):3373-3405.

PMID: 38943004 PMC: 11316026. DOI: 10.1038/s44319-024-00187-6.


A Narrative Review Discussing Vasectomy-Related Impact upon the Status of Oxidative Stress and Inflammation Biomarkers and Semen Microbiota.

Doroftei B, Ilie O, Maftei R, Scripcariu I, Armeanu T, Stoian I J Clin Med. 2023; 12(7).

PMID: 37048754 PMC: 10095584. DOI: 10.3390/jcm12072671.


How to improve the clinical outcome of round spermatid injection (ROSI) into the oocyte: Correction of epigenetic abnormalities.

Tanaka A, Watanabe S Reprod Med Biol. 2023; 22(1):e12503.

PMID: 36789269 PMC: 9909386. DOI: 10.1002/rmb2.12503.

References
1.
Okuwaki M, Sumi A, Hisaoka M, Saotome-Nakamura A, Akashi S, Nishimura Y . Function of homo- and hetero-oligomers of human nucleoplasmin/nucleophosmin family proteins NPM1, NPM2 and NPM3 during sperm chromatin remodeling. Nucleic Acids Res. 2012; 40(11):4861-78. PMC: 3367197. DOI: 10.1093/nar/gks162. View

2.
Tesarik J, Mendoza C . Spermatid injection into human oocytes. I. Laboratory techniques and special features of zygote development. Hum Reprod. 1996; 11(4):772-9. DOI: 10.1093/oxfordjournals.humrep.a019253. View

3.
Hosseini S, Salehi M . Tricostatin A-treated round spermatid enhances preimplantation embryo developmental competency following round spermatid injection in mice. Zygote. 2021; 30(3):373-379. DOI: 10.1017/S0967199421000836. View

4.
Hiura H, Okae H, Chiba H, Miyauchi N, Sato F, Sato A . Imprinting methylation errors in ART. Reprod Med Biol. 2014; 13(4):193-202. PMC: 4182590. DOI: 10.1007/s12522-014-0183-3. View

5.
Antinori S, Versaci C, Dani G, Antinori M, Selman H . Successful fertilization and pregnancy after injection of frozen-thawed round spermatids into human oocytes. Hum Reprod. 1997; 12(3):554-6. DOI: 10.1093/humrep/12.3.554. View